Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
STTK · against 471 other Healthcare companies of similar size
Ranked #304 of 472 · scores higher than 12% of peers
Bars: peers in each 10-point band of the valuation score169 peers with a valuation score of 0–9, including STTK · Click a bar to see the companies
Mainly because of its EBITDA yield, earnings yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | STTK | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 459 reported | -8.0% | 0.5% | 26% | 30% | |
| EBITDA yieldHigher is better · 477 reported | -15.2% | 3.6% | 16% | 50% | |
| Free cash flow yieldHigher is better · 201 reported | -7.5% | -5.3% | 47% | 20% | |
| Book yieldHigher is better · 469 reported | 38.3% | 47.5% | 40% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 6.50T IDR (≈$403M) | 99 | 69 | |
| 304 | 588M USD | 8 | 24 | |
| 304 | 303M USD | 8 | 27 | |
| 304 | 354M USD | 8 | 13 | |
| 304 | 467M USD | 8 | 44 | |
| 304 | 549M USD | 8 | 30 | |
| 304 | 976M USD | 8 | 36 | |
| 304 | 371M USD | 8 | ||
| 304 | 394M USD | 8 | 37 | |
| 304 | 513M USD | 8 | 31 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score